Innovotech Net Debt per Share
Net Debt per Share of Innovotech (IOT.V) as of Oct 16, 2026.
Get this data via API
Financial Data API
Net Debt per Share
0.00CAD
YoY
702.35%
Last updated:
Net Debt per Share of Innovotech is 2025 0.00 CAD. Net Debt per Share of Innovotech was 2024 0.00 CAD. It decreases by 702.35% higher compared to the previous year.
The Innovotech Net Debt per Share history
3 Years
10 Years
25 Years
Max
Net Debt per Share
Date
Net Debt per Share
Jan 1, 2014
0.00 CAD
Jan 1, 2015
0.00 CAD
Jan 1, 2016
0.00 CAD
Jan 1, 2017
0.00 CAD
Jan 1, 2018
0.00 CAD
Jan 1, 2019
0.00 CAD
Jan 1, 2020
0.00 CAD
Jan 1, 2025
0.00 CAD
| YEAR | Net Debt per Share | YoY |
|---|---|---|
| 0.00CAD | +702.35% | |
| 0.00CAD | -80.00% | |
| 0.00CAD | 0.00% | |
| 0.00CAD | -4.76% | |
| 0.00CAD | -16.00% | |
| 0.00CAD | +11.11% | |
| 0.00CAD | 0.00% | |
| 0.00CAD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Innovotech Stock analysis
What does Innovotech do? Innovotech Inc is a company based in Edmonton, Alberta, Canada, operating within the Health Care sector, specifically in the Life Sciences Tools & Services industry. The company went public on May 28, 2003, with its ticker symbol IOT.V and ISIN CA45772U1049. Innovotech Inc. focuses on proprietary assay kits used in microbial biofilm research, offering a range of services and products related to antimicrobial testing and biofilm analysis. The company provides contract research services including Antimicrobial Contract Research, testing for Minimum Inhibitory Concentration (MIC) and Minimum Biofilm Eradication Concentration (MBEC), and specialized testing for antimicrobial and anti-biofilm materials. Additionally, Innovotech offers services such as Bacteriophage Testing, Customized Antimicrobial Testing, and Analytical Capabilities. The company also markets MBEC Assay Kits, Order Biofilm Assays, and Coated MBEC Assay Lids. Innovotech Inc. is involved in biofilm research, including scientific publications and a SEM Library, and develops antimicrobial silver products like AgreGuard-1 Silver Antimicrobial for crop protection and InnovoSIL Antimicrobial Silver Products. The company's website is https://innovotech.ca/. Innovotech is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Innovotech stock
On Eulerpool you can find the complete historical development of Net Debt per Share Innovotech since 2006 – with annual values, charts, and detailed analysis.
Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Other — Innovotech
All Key Metrics — Innovotech
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth